In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

Researchers have created a remarkable new map of a key part of our brain, the hypothalamus, that will lead to new ways of ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ways they affect the body—both helpful and harmful—beyond reducing weight.

Weight-loss jabs, such as Ozempic, Wegovy and Mounjaro, have quickly earned a glowing global reputation for shifting the ...

Studies have suggested that GLP-1RAs may show promise for a host of conditions, from alcohol use disorder to Parkinson’s. But ...

As evidence has mounted that new diabetes and weight loss drugs can provide a variety ... s semaglutide for heart disease and Eli Lilly’s tirzepatide for sleep apnea. Now, as the companies ...

The newest weight-loss drugs, Wegovy and Zepbound ... In report published in Nature Medicine, Dr. Ziyad Al-Aly, chief of research and development at the VA St. Louis Health Care System and ...

The study was published this week in the journal Nature Medicine ... apnea FDA says shortage of GLP-1 drug tirzepatide is over Merck reaches weight-loss drug deal worth up to $2 billion with ...

Weight loss is a common goal for many, and while diet and exercise remain essential, some turn to medications like Mounjaro (tirzepatide) for additional support. These medications work by targeting ...

The use of weight ... loss jabs may be associated with wider health benefits including lower risk of stroke and dementia, a study has suggested. The research, published in the scientific journal ...